arrow
S

Stephen Evans

London School of Hygiene & Tropical Medicine
H指数:85
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases

sotrovimab和molnupiravir预防肾脏替代治疗患者严重新型冠状病毒肺炎结局的比较有效性: 使用OpenSAFELY-UKRR和SRR数据库的观察性研究

2023-08-292
OAAI
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data

使用观察数据估计新型冠状病毒肺炎疫苗接种有效性的挑战

2023-05-0112
OA
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

社区环境中抗病毒药物和中和单克隆抗体新型冠状病毒肺炎接受者的趋势,变化和临床特征: 对OpenSAFELY 2340万人的回顾性描述性队列研究

2023-01-139
OAAI
Identifying Patterns of Clinical Interest in Clinicians? Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review

确定临床医生的临床兴趣模式?治疗偏好: 无假设的数据科学方法优先考虑临床审查的异常值

2022-12-201
OAAI
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

索特罗维单抗和莫那比拉韦预防社区患者严重新型冠状病毒肺炎结局的疗效比较: OpenSAFELY平台的观察性队列研究

2022-11-1644
OAAI
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY

ChAdOx1与BNT162b2新型冠状病毒肺炎疫苗在英格兰卫生和社会护理工作者中的比较有效性: 使用OpenSAFELY的队列研究

2022-07-2010
OAAI
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY

描述在英格兰第二次接种疫苗后经历新型冠状病毒肺炎疫苗突破的人群: 来自OpenSAFELY的队列研究

2022-07-0519
OAAI
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform

与免疫介导的炎症性疾病和免疫修饰疗法相关的严重新型冠状病毒肺炎结局风险: OpenSAFELY平台的一项全国性队列研究

2022-07-0168
OAAI
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY

对机械心脏瓣膜患者可能不适当的doac处方: 使用OpenSAFELY对5790万名患者的初级保健记录进行联合分析

2022-03-014
OAAI
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65

新型冠状病毒肺炎大流行第一波和第二波期间英格兰疗养院居民的死亡率: 一项对430万名65岁以上成年人的观察性研究

2022-03-0130
OA
Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study

口服抗凝剂与COVID-19-related结局的关系: 一项基于人群的队列研究

2022-02-165
OAAI
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform

英格兰新型冠状病毒肺炎住院后的总体和特定原因住院和死亡: 在OpenSAFELY平台上使用链接的初级保健,二级保健和死亡登记数据的队列研究

2022-01-2538
OAAI
Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study

与直接口服抗凝药相比,华法林与COVID-19-related结局之间的关系: 基于人群的队列研究

2021-10-1911
OAAI
Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records in situ using OpenSAFELY

57.9百万新型冠状病毒肺炎疫苗接种者的趋势和临床特征: 使用OpenSAFELY对患者的初级保健记录进行原位联合分析

2021-09-2446
OAAI
OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19

OpenSAFELY NHS服务恢复观察站1: 第一波新型冠状病毒肺炎期间英格兰的初级保健临床活动

2021-09-2423
OAAI